In accordance with previous observations35, colorectal cancer organoids in a high IGF1R signaling state were less responsive to EGFR inhibitors and more responsive to IGF1R and MEK blockade, demonstrating the central role of IGF1R mediated mitogen activated protein kinase (IGFR1-MAPK) signaling. The gene discussed is WNK2; the disease is colorectal cancer.